Clinical Research

Indian Health Outcomes, Public Health and Economics Research Centre (IHOPE) Read More

Clinical Research

LVPEI has been successfully audited by United States - Food and Drug Administration Agency (US FDA) and European Medicine Agency (EMA) for performing clinical trials.

Raja Narayanan, Director, Clinical Research
Contact: 040 68102618
Mail: narayanan@lvpei.org


Kallam Anji Reddy Campus
Administrator: T. Charitha
Study Coordinators: Vijaya, Ramya, Kalpana, Kavya
Study Optometrist: Manindra, Subba Rao
Contact Numbers (Clinical Research): 040-68102123/2124

Image reading centre:
Graders: Renuka Sai Contact Number: 040-6810 2170

Bhubaneswar Campus-Clinical Research

Clinical Research Coordinators: Asit, Suprateeka, Rojalin, SatyaPrakash
Ethics Committee Coordinator: Mohammed Hasibur Rahman
Study Optometrists: Kartik Jana
Contact Number: 06740 2653261


GMRV Campus-Clinical Research
Clinical Research Coordinator: Sumitra, Aishwarya
Contact Number: 9515263101 / 9182211204

KAR CAMPUS
S.No Name of the project Principal Investigator Supported By Duration CTRI
1Prospective, Investigator Initiated study to evaluate, biocompatibility and indicative effectiveness of the Endo Art in subjects having corneal edema with no visual potentialDr.Sunita ChaurasiaEYEYON2021-2023http://ctri.nic.in
2Prospective, Investigator Initiated Study to Evaluate the Safety, and Indicative Effectiveness of Xenia™ in Subjects Having Keratoconus Dr.Pravin KrishnaGebauer2021-2023http://ctri.nic.in
3Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS)Dr.Padmaja KumariNovanordisk2020-2025http://ctri.nic.in
4A Double Masked, Parallel Group, Randomized, Multicenter, Clinical Study to Compare Efficacy and Safety of Intas Ranibizumab with Lucentis@ in Patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD)"Dr.Raja NarayananDr.Raja Narayanan2021-2023http://ctri.nic.in
5A real-world, prospective, multi-center, open-label, phase IV clinical study to evaluate the safety and effectiveness of intravitreal injections (IVI) of brolucizumab in patients with neovascular age-related macular degeneration (nAMD).Dr.Vishal RavalNovartis2022-2023http://ctri.nic.in
6A phase 3 multicentre, double masked, Randomised, study to evaluate the efficacy and safety of intravitreal OPT-302 in combination with Aflibercept, compared with Aflibercept alone in patients with neovascular age related macular degeneration.Dr.Brijesh TakkarIQVIA2022-2023http://ctri.nic.in
7Multi-Parameter Analysis of Tear Film of Healthy and Suspected Dry Eye Patients using TeaRx Non-Invasive Point-of-care Testing Device: An Investigator Initiated Academic TrialDr.Sayan BasuDiagnostear2021-2023http://ctri.nic.in
8A Phase IV interventional post approval trial to assess the safety of intravitreal aflibercept for the treatment of diabetic macular edema (DME) in patients in India.Dr.Vishal RavalBayer2022-2023http://ctri.nic.in
9A randomized double masked parallel group multicenter clinical study to evaluate efficacy and safety of AVT 06 compared with EU-Eylea in subjects with neovascular Wet) age related macular degeneration (ALVOEYE)Dr.Vivek DaveALVOTEC2023-2024http://ctri.nic.in

BBSR CAMPUS
S.No Name Of The Project Principal Investigator Supported By Duration CTRI
1A phase 3 multicentre, double masked, Randomised, study to evaluate the efficacy and safety of intravitreal OPT-302 in combination with Aflibercept, compared with Aflibercept alone in patients with neovascular age related macular degeneration.Dr.Tapas RanjanIQVIA2022-2023http://ctri.nic.in
2A Randomized, Active-Controlled, Double-Masked, Parallel-Group, Phase 3 Study to Compare Efficacy and Safety of CT-P42 in comparison with Eylea in Patients with Diabetic Macular Edema.Dr.Umesh ChandraSyneos Health2021-2023http://ctri.nic.in
3A Phase 2, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution Compared to Placebo in the Treatment of Adenoviral ConjunctivitisDr.Sujata DasINNVOCEPT2023-2024https://clinicaltrials.gov

GMRV CAMPUS
S.No Name of the Project Principal Investigator Supported By Duration CTRI
1A Randomized, Active-Controlled, Double-Masked, Parallel-Group, Phase 3 Study to Compare Efficacy and Safety of CT-P42 in comparison with Eylea in Patients with Diabetic Macular Edema.Dr.Bhavik PanchalSyneos Health2021-2023http://ctri.nic.in